10-QPeriod: Q1 FY2007

COLGATE PALMOLIVE CO Quarterly Report for Q1 Ended Mar 31, 2007

Filed April 26, 2007For Securities:CL

Summary

Colgate-Palmolive Company's first quarter 2007 report shows robust top-line growth, with net sales increasing by 12.0% to $3.21 billion, driven by strong volume increases of 8.0% and modest price increases. The company demonstrated significant profit improvement, with net income soaring by 49.3% to $486.6 million and diluted earnings per share rising to $0.89 from $0.59 in the prior year period. This performance was bolstered by a gain from the sale of Latin American bleach brands and a substantial tax benefit related to a valuation allowance reduction in Brazil. The company's core Oral, Personal and Home Care segment and its Pet Nutrition segment both exhibited strong sales growth, reflecting effective new product introductions and market share gains across various geographies. Despite increased advertising spending and ongoing restructuring charges, the company successfully improved its gross profit margin and operating profit, underscoring its focus on higher-margin businesses and cost-efficiency initiatives. Management expressed confidence in continued growth, supported by global brand strength and diverse market presence.

Key Highlights

  • 1Net sales increased by a robust 12.0% to $3.21 billion, driven by 8.0% volume growth and 1.0% price increases.
  • 2Net income saw a significant jump of 49.3% to $486.6 million, with diluted EPS growing to $0.89 from $0.59 year-over-year.
  • 3Operating profit increased by 26% to $651.1 million, benefiting from higher gross profit margins and a gain on the sale of Latin American bleach brands.
  • 4The company recorded a substantial tax benefit of $73.9 million related to the reduction of a valuation allowance for deferred tax assets in Brazil.
  • 5The 2004 Restructuring Program was expanded, increasing estimated pretax charges to $925-$1,075 million, with projected annual savings now ranging from $400-$475 million by 2008.
  • 6Hill's Pet Nutrition sales grew 12.0%, despite a voluntary recall of two feline products due to melamine concerns in wheat gluten supplies; the impact is not expected to be significant.
  • 7Significant debt management activities occurred, with principal payments on debt totaling $714.6 million and proceeds from debt issuance at $653.2 million.

Frequently Asked Questions

The significant increase in net income and EPS was driven by several factors including robust sales growth, improved gross profit margins, a gain of $48.6 million from the sale of Latin American household bleach business, and a substantial income tax benefit of $73.9 million resulting from the reduction of a tax loss carryforward valuation allowance in Brazil. These positive impacts were partially offset by restructuring charges and costs related to a voluntary recall of certain pet food products.

The 2004 Restructuring Program is progressing on schedule and has been expanded to include additional savings projects. The estimated cumulative pretax charges are now projected to be between $925 and $1,075 million (from $750-$900 million previously), with annual savings now expected to be between $400 and $475 million (from $325-$400 million previously) by 2008. For the first quarter of 2007, pretax restructuring charges totaled $45.9 million.

Hill's Pet Nutrition voluntarily recalled two feline products as a precaution due to potential contamination from melamine in wheat gluten supplies. These products represented a small portion (0.5%) of Hill's annual net sales. The company does not anticipate this recall to have a significant impact on its 2007 annual net sales or operating profit, with associated costs being recorded in the Corporate segment.

Colgate-Palmolive is involved in several ongoing legal and tax matters, including assessments from Mexican tax authorities related to VAT credits and transfer pricing, and disputes regarding interest deductions and foreign exchange losses in Brazil stemming from the Kolynos acquisition. While management believes the company will prevail in these matters, these contingent liabilities are being actively managed and contested.